JenaValve Technology GmbH (Munich, Germany) is a medical device company specialized in developing minimally-invasive heart valve replacement systems. JenaValve’s unique design and state-of-the-art engineering has garnered international recognition, positioning the company to become one of the leaders in this highly specialized medical device area. The company’s first product – launched in October 2011 – has shown very good clinical performance on all relevant clinical features. The second product, a transfemoral implant, is scheduled for approval by 2H 2017.
Claus Andersson, PhD
|Mobile:||+45 22 70 50 65|